Search Bar & Filters
Found 8 Actively Recruiting clinical trials
Actively Recruiting
Researchers are evaluating whether transcranial photobiomodulation t-PBM, a light-based brain therapy, can improve memory and thinking skills in older adults with amnestic mild cognitive impairment aMCI. This condition involves memory problems greater than normal aging and may increase the risk of Alzheimers disease. The study also aims to see if t-PBM changes how brain areas communicate, especially within the default mode network DMN. Participants will be randomly assigned to receive either active t-PBM or a sham inactive version, both combined with cognitive training. Each participant will take part in eight 20-minute sessions where the device is placed on the head during cognitive exercises. The active device delivers near-infrared light at gamma frequency, while the sham device looks and sounds the same but does not emit therapeutic light. The cognitive rehabilitation program involves pen-and-paper tasks targeting attention, memory, executive function, and language, with difficulty increasing over sessions. Participants will provide a blood sample for genetic testing and undergo brain fMRI scans before and after the 4-week intervention to measure brain connectivity changes. They will also complete cognitive tests and meet with a dietitian at the start and end of the study to monitor diet stability. Researchers will measure changes in cognitive abilities using the Montreal Cognitive Assessment MoCA and changes in brain network connectivity using resting-state fMRI. The study includes monitoring of genetic factors to explore how they might influence treatment responses.
Actively Recruiting
Researchers are investigating how different ultrasound measurements relate to the level of tactile sensation in patients with carpal tunnel syndrome CTS, a common nerve compression condition. The study focuses on patients with mild to moderate CTS diagnosed through electrodiagnostic tests. It aims to understand how ultrasound parameters used in diagnosis connect to sensory complaints, such as numbness and sensory loss, which affect daily hand use. The study involves diagnostic tests including nerve conduction studies that measure sensory and motor responses in the upper limbs, median nerve ultrasound to assess nerve size and characteristics, and tactile sensory tests to evaluate sensory function. These assessments will help explore the relationship between ultrasound findings and the level of sensory disturbance in patients with CTS. Participants will undergo various evaluations over three months, including ultrasound scans of the median nerve and sensory tests like two-point discrimination and the Semmes Weinstein test. Questionnaires on symptom severity and quality of life will also be completed. The research team will monitor these outcomes to better understand sensory changes in CTS and their association with ultrasound measures.
Actively Recruiting
Researchers are studying the long-term safety and effectiveness of pembrolizumab MK-3475 in participants with advanced tumors or blood cancers who were part of previous pembrolizumab-based studies. This extension study includes participants currently receiving treatment or in follow-up from parent trials. It consists of three phases the First Course Phase, Survival Follow-up Phase, and Second Course Phase, depending on the participants status at the end of their previous study. Participants may receive pembrolizumab alone or combined with standard of care treatments, lenvatinib, or other study drugs like olaparib and MK-4280, delivered mainly by intravenous infusion or oral capsules. Dosing schedules vary, including pembrolizumab administered every 3 or 6 weeks for up to 35 or 17 doses depending on the phase. Some participants may take lenvatinib orally daily, timed with pembrolizumab infusions, while others may receive investigational combination therapies or standard care treatments according to their parent studys protocol. During the study, participants will have regular infusions or oral dosing and be monitored over several years for overall survival and other outcomes like progression-free survival and adverse events. Researchers will assess safety and efficacy for up to approximately 10 years, with detailed tracking of side effects and treatment discontinuations. Study visits and assessments will be conducted to evaluate organ function, disease status, and any treatment-related effects throughout the study duration.
Actively Recruiting
Researchers are conducting an observational study to screen adults aged 18 and over who visit hospital outpatient clinics in Turkey for malnutrition and sarcopenia risks. The study focuses on patients attending oncology, neurology, and geriatric clinics to better understand these conditions across diverse patient groups. This non-interventional, cross-sectional design means participants are observed without receiving experimental treatments. Participants are screened once during their outpatient visit without any study treatments or interventions. The study collects information on malnutrition risk, sarcopenia risk, body mass index, calf circumference, hand grip strength, biochemical parameters, healthcare use, and nutrition treatments. Data is gathered on the screening day only. During the study visit, researchers will assess physical and biochemical measures to evaluate nutrition and muscle health. Participants provide informed consent before any assessments. The study measures malnutrition and sarcopenia risks as primary outcomes on the first day and includes several secondary measures related to body composition and healthcare use. The study will continue enrolling participants until April 2027.
Actively Recruiting
Researchers are evaluating the new medicine PF-08634404 in combination with chemotherapy compared to the current standard treatment pembrolizumab with chemotherapy for adults with locally advanced or metastatic non-small cell lung cancer NSCLC. The study includes adults with Stage IIIBIIIC or Stage IV squamous or non-squamous NSCLC who are not candidates for surgery or curative chemoradiotherapy and have not received prior treatment for advanced disease. Participants are assigned to two parts based on tumor type squamous NSCLC Part 1 or non-squamous NSCLC Part 2. Each participant is randomly assigned to receive either PF-08634404 or pembrolizumab with chemotherapy followed by maintenance therapy. Treatment is given through intravenous infusions in cycles, continuing as long as it is effective and safe. Different chemotherapy regimens are used depending on the tumor type. Throughout the study, participants attend regular visits for treatment and health monitoring. Cancer response is assessed every 6 weeks for the first 48 weeks and then every 12 weeks. Researchers will measure overall survival, progression-free survival, objective response rates, duration of response, adverse events, laboratory results, drug levels, immune response, and quality of life using questionnaires. The study lasts up to approximately 39 months with ongoing safety and effectiveness evaluations.
Actively Recruiting
Healthy Volunteer
Researchers are evaluating new teaching methods to improve nursing students skills in urinary catheterization, a common but complex procedure that can lead to serious infections if done incorrectly. This study compares the Pecha Kucha presentation style, known for its concise and timed slides, with traditional demonstration and no additional training to see which method better enhances students knowledge and practical abilities. All participating students first attend a theoretical course that includes a lecture and an educational video on catheterization. Afterward, they study materials independently at home. One week later, before their lab practice, they are randomly assigned to one of three groups one receives a Pecha Kucha presentation, another a traditional instructor-led demonstration on a mannequin, and the last group receives no extra training before performing the procedure. Participants skill performance is assessed immediately after the training, including the time taken to complete the procedure and their satisfaction with the educational experience. The study aims to identify which teaching approach offers the most effective learning and skill development during nursing education, with all activities and evaluations completed within a short timeframe after the interventions.
Actively Recruiting
Researchers are evaluating how well ultrasound imaging can detect damage to the radial nerve in patients with broken upper arm bones humeral shaft fractures. Some patients have weakness or paralysis in their hand and wrist caused by radial nerve injury. The study compares patients with and without these nerve problems to see if early ultrasound scans can accurately identify nerve damage before surgery. All patients will receive standard treatment, including surgery to fix the broken bone. Those who have nerve problems will have the nerve examined during surgery. High-resolution ultrasound scans of the radial nerve will be performed within 48 hours of admission to assess nerve continuity and damage type. The ultrasound results will be compared to what surgeons find during the operation. Participants will be closely followed for 12 months after surgery to monitor nerve recovery, bone healing, and any complications. Researchers will assess the accuracy of the ultrasound in detecting nerve continuity before surgery and track the functional recovery of motor and sensory nerve function at 1, 3, 6, and 12 months postoperatively. This long-term monitoring aims to improve early diagnosis and management of nerve injuries in arm fractures using non-invasive ultrasound scans.
Actively Recruiting
Healthy Volunteer
Researchers are evaluating the effects of video-based self-assessment within simulation-based neonatal resuscitation skills training for fourth-year midwifery students. The study aims to assess how this video review impacts neonatal resuscitation skills, clinical judgment, student satisfaction, and self-confidence. It uses a randomized, parallel design to compare students who use video self-assessment with those who do not. Participants undergo nine weeks of neonatal resuscitation training based on Neonatal Resuscitation Program guidelines. Both groups receive theoretical training through an 8-week PowerPoint course, followed by standardized simulation practice and debriefing sessions. The intervention group reviews video recordings of their own simulation performances to self-assess, while the control group does not. Both groups attend researcher-led debriefings, and control participants can review their videos only after the study concludes. Participants are assessed at three points before the training, immediately after, and four weeks post-training. Outcomes measured include neonatal resuscitation skills using a specific assessment form, clinical judgment with the Lasater Clinical Judgment Rubric, and student satisfaction and self-confidence via the Student Satisfaction and Self-Confidence in Learning Scale. The study also monitors attendance and consent, with ethics approval granted for this non-drug educational research.